Drugs
-
AIP4, Alzheimer’s disease, amyloid beta, APP PS1 mice, Brain, cell cycle re-entry, clomipramine, drug repurposing, Drugs, Itch, memory, Neurodegenerative Diseases, neuronal apoptosisClomipramine Improved Alzheimer’s Mouse Memory by Blocking Itch in 45 Days
A 2026 iScience study found that 45 days of clomipramine improved spatial,…
-
adenosine, black tea, caffeine, caffeine timing, coffee, Drugs, PSQI, Psychiatry, Psychology, sleep, sleep disturbances, sleep duration, sleep quality, working adultsCaffeine Intake and Sleep Quality: 428 Working Adults, Source by Source
A 2026 cross-sectional study involving 428 employed adults found that poor sleepers…
-
anti-obesity medication, Diet & Nutrition, Drugs, effort moralization, GLP-1, medication stigma, moral judgment, obesity stigma, Ozempic, Psychology, semaglutide, social psychology, Wegovy, weight stigma, Weight-loss drugsGLP-1 Weight-Loss Drugs Triggered Effort-Based Stigma in 4 Studies
A 2026 Scientific Reports paper involving 1,205 participants found that people using…
-
addiction, adolescents, alcohol, Cannabis, Drugs, meta-analysis, prevalence, Prevention, public-health, South Africa, substance use, tobaccoTeen Substance Use in South Africa: 30-Study Meta-Analysis
A 2026 PRISMA-compliant systematic review and meta-analysis in Drug and Alcohol Review…
-
AD/ADRD, Alzheimer’s disease, APOE-e4, Brain, cardiovascular risk, cognitive decline, Dementia, Drugs, Kaiser Permanente, LDL cholesterol, Neurodegenerative Diseases, observational bias, statins, target trial emulationStatins and Dementia Risk: No Long-Term Signal in 322,358 Patients
Statins do not look like a dementia-prevention drug, but they do not…
-
Immunotherapy could be used to treat depression, early trial suggests
Immunotherapy could be used to treat depression among patients who have not…
-
addiction, blood pressure, Cannabis, cardiovascular risk, Drugs, Hormones, hypertension, marijuana, nuMoM2b, postpartum health, postpartum mood, self-medication, side effects, thc, women’s healthCannabis After Pregnancy Did Not Increase Hypertension Risk in nuMoM2b
A 2026 nuMoM2b Heart Health Study analysis tested whether urine-confirmed cannabis exposure…
-
ADHD, atomoxetine, cheating behavior, cognitive enhancement, dishonesty, dopamine, Drugs, methylphenidate, Neurotransmitters, norepinephrine, Psychology, ritalin, smart drugs, Stimulants, strattera, striatal dopamineMethylphenidate Reduced Dishonesty and Cheating in 151 Adults; Atomoxetine Had No Effect
A 2026 double-blind randomized controlled trial by Kappes et al. in Psychopharmacology…
-
adverse effects, antidepressants, depression, depression treatment, Drugs, global mental health, low- and middle-income countries, Pakistan, pharmacovigilance, prescribing patterns, Psychiatry, Psychology, side effects, ssris, tricyclicsAntidepressant Use in Pakistan (2026): SSRI Prescribing Patterns and Patient-Reported Side Effects
Most antidepressant pharmacovigilance data come from high-income countries, leaving prescribing patterns and…
-
ADNI, Alzheimer’s disease, amyloid, APOE, APOE-e4, blood biomarker, Brain, cognition, donanemab, Drugs, genetics, lecanemab, longitudinal cohort, mild cognitive impairment, Neurodegenerative Diseases, neuroscience, p-tau217, preclinical ADPlasma p-tau217 Blood Test Predicts Alzheimer’s Risk 1.5x Stronger in APOE-e4
Until recently, Alzheimer’s pathology could only be confirmed in living patients via…
